Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Oncotarget, 10.2019, 58, S. 6138-6151
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2019
- Urheber
- DOI
-
10.18632/oncotarget.27242
- URN
-
urn:nbn:de:hebis:30:3-755514
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Merker, Michael
- Meister, Michael
- Heinze, Annekathrin Maria Brigitte
- Jarisch, Andrea
- Sörensen, Jan
- Hünecke, Sabine
- Bremm, Melanie
- Cappel, Claudia
- Klingebiel, Thomas
- Bader, Peter
- Rettinger, Eva
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2019
Ähnliche Objekte (12)
Adoptive immunotherapy against ovarian cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunotherapy in Rare Cancers
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Cellular immunotherapy for refractory hematological malignancies
Immunotherapy : new options in gastrointestinal cancers?
Adoptive immunotherapy against ovarian cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunotherapy in Rare Cancers
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Cellular immunotherapy for refractory hematological malignancies
Immunotherapy : new options in gastrointestinal cancers?
Adoptive immunotherapy against ovarian cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunotherapy in Rare Cancers
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Cellular immunotherapy for refractory hematological malignancies